The mean corpuscular volume (MCV) in children with acute lymphoblastic leukemia
Insights
Anemia in acute lymphoblastic leukemia (ALL) is not fully understood. This study found that an increased mean corpuscular volume (MCV) in ALL patients suggests a potential maturation defect, not just cell crowding.
Area of Science:
- Hematology
- Pediatric Oncology
Background:
- Anemia is common in children diagnosed with acute lymphoblastic leukemia (ALL).
- The underlying causes of anemia in ALL remain largely unclear.
- Mean corpuscular volume (MCV) is a red blood cell size indicator, with smaller cells typically seen in reduced production.
Purpose of the Study:
- To investigate the characteristics of anemia in pediatric ALL patients.
- To analyze the mean corpuscular volume (MCV) at diagnosis to understand anemia etiology.
- To determine if MCV can reflect red blood cell age or indicate other underlying mechanisms in ALL.
Main Methods:
- Analysis of MCV at diagnosis in 54 pediatric ALL patients.
- Correlation of MCV values with hemoglobin and platelet counts.
- Comparison of MCV at diagnosis and relapse.
- Examination of demographic factors, including sex, in relation to MCV.
Main Results:
- 61% of patients had normal MCV, 33% had increased MCV, and 6% had decreased MCV.
- Increased MCV was associated with lower hemoglobin and platelet counts.
- A higher percentage of females presented with increased MCV (83%) compared to normal MCV (43%).
- At relapse, 71% of patients with initially increased MCV maintained elevated MCV, versus 23% with initially normal MCV.
Conclusions:
- Elevated MCV in ALL patients may indicate a cell maturation defect affecting multiple cell lines, possibly due to leukemic cell factors.
- MCV is not a reliable indicator of mean red blood cell age in ALL.
- The findings challenge the 'crowding-out' hypothesis as the sole explanation for anemia in ALL.
Abstract:
Although most children with acute lymphoblastic leukemia (ALL) are anemic at the time of diagnosis, the cause of this anemia remains obscure. In an effort to characterize the anemia, we analyzed the mean corpuscular volume (MCV) at the time of diagnosis. The MCV was selected because of the observation that older erythrocytes have a reduced MCV and an anemia presumably related to decreased red blood cell production should be reflected by a reduced MCV. A total of 54 patients fulfilled the criteria for analysis. Of this group, 33 per cent had an increased MCV, 61 per cent had a normal MCV, and 6 per cent had a decreased MCV for age. Patients with an increased MCV were found to have a significantly lower hemoglobin and platelet count. The number of females in the group with the increased MCV was 83 per cent as contrasted with 43 per cent in the group with a normal MCV. At relapse, 71 per cent of patients with an initially increased MCV had an elevated MCV as contrasted with only 23 per cent in the group with an initially normal MCV. These observations suggest that in patients with ALL and an increased MCV, a maturation defect may be present that affects all cell lines and may be the result of a diffusible substance released from the leukemic cells. The MCV cannot be used as a reflection of mean cell age in patients with ALL and does not support the belief that the anemia in ALL is merely the result of a "crowding-out" process.
